Calibr

Calibr company information, Employees & Contact Information

Explore related pages

Related company profiles:

Calibr is a Generative AI powered e-learning platform for modern day organisations. Calibr offers unified Learning Experience Platform (LXP) and Learning Management System (LMS) along with a Generative AI enabled course authoring platform. Create interactive courses using our course authoring tool, share with your colleagues and spread knowledge. Manage employee onboarding, employee training, compliance training, customer training, partner training all under a single platform. Access thousands of ready to use courses, videos and e-books from our content library. Get real time analytics to see how your organisation is learning and bridging the skill gap with Calibr.

Company Details

Employees
27
Founded
-
Address
30 N Gould St, Sheridan,wyoming 82801,united States
Industry
E-Learning Providers
HQ
Sheridan, Wyoming
Looking for a particular Calibr employee's phone or email?

Calibr Questions

News

Calibr-Skaggs doses first patient with switchable CAR-T cell therapy in a phase 1 trial for metastatic breast cancer - Scripps Research

Calibr-Skaggs doses first patient with switchable CAR-T cell therapy in a phase 1 trial for metastatic breast cancer Scripps Research

FDA clears Calibr-Skaggs’ IND for Phase I trial of sCAR-T therapy - Clinical Trials Arena

FDA clears Calibr-Skaggs’ IND for Phase I trial of sCAR-T therapy Clinical Trials Arena

Transforming business through continuous learning: How Calibr is shaping the future of talent development - YourStory.com

Transforming business through continuous learning: How Calibr is shaping the future of talent development YourStory.com

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases - News-Medical

Calibr-Skaggs receives FDA approval to test sCAR-T therapy in patients with autoimmune diseases News-Medical

Using AI To Predict Multispecific Formulation Patterns - Bioprocess Online

Using AI To Predict Multispecific Formulation Patterns Bioprocess Online

Calibr-Skaggs Administers First Patient with Switchable CAR-T Cell Therapy - Bioengineer.org

Calibr-Skaggs Administers First Patient with Switchable CAR-T Cell Therapy Bioengineer.org

Caliber Stock Jumps Over 2000% Pre-Market – Here’s Why - Stocktwits

Caliber Stock Jumps Over 2000% Pre-Market – Here’s Why Stocktwits

Viome and Scripps Research partner to develop first at-home RNA screening test to prevent colon cancer before it strikes - Scripps Research

Viome and Scripps Research partner to develop first at-home RNA screening test to prevent colon cancer before it strikes Scripps Research

AbbVie, Calibr expand partnership for clinical assets - Pharmaceutical Technology

AbbVie, Calibr expand partnership for clinical assets Pharmaceutical Technology

AbbVie invests in Calibr’s switchable CAR-T therapy  - ACS Publications

AbbVie invests in Calibr’s switchable CAR-T therapy  ACS Publications

NetApp Excellerator Showcases AI and EdTech Pioneers from 13th Cohort - digital terminal

NetApp Excellerator Showcases AI and EdTech Pioneers from 13th Cohort digital terminal

Calibr improves spectral library search for spectrum-centric analysis of data independent acquisition proteomics - Nature

Calibr improves spectral library search for spectrum-centric analysis of data independent acquisition proteomics Nature

Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound - PR Newswire

Calibr and Bill & Melinda Gates Medical Research Institute announce licensing agreement for novel candidate tuberculosis treatment compound PR Newswire

Calibr-Skaggs announces initial dosing of a first-in-class regenerative lung medicine in a phase 1 trial for idiopathic pulmonary fibrosis - Scripps Research

Calibr-Skaggs announces initial dosing of a first-in-class regenerative lung medicine in a phase 1 trial for idiopathic pulmonary fibrosis Scripps Research

Calibr announces license agreement with Gilead to develop a long-acting HIV antiviral agent for treatment in combination with lenacapavir - Scripps Research

Calibr announces license agreement with Gilead to develop a long-acting HIV antiviral agent for treatment in combination with lenacapavir Scripps Research

Calibr advances multiple clinical programs while securing significant funding for global health and other disease initiatives - Scripps Research

Calibr advances multiple clinical programs while securing significant funding for global health and other disease initiatives Scripps Research

Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines - Scripps Research

Three decades of giving: Announcing the Calibr-Skaggs Institute for Innovative Medicines Scripps Research

Calibr partners with Wellcome Trust to create consortium for neglected tropical diseases - Scripps Research

Calibr partners with Wellcome Trust to create consortium for neglected tropical diseases Scripps Research

FDA grants Fast Track designation to Calibr’s ‘switchable’ CAR-T cell cancer therapy, CLBR001 + SWI019 - Scripps Research

FDA grants Fast Track designation to Calibr’s ‘switchable’ CAR-T cell cancer therapy, CLBR001 + SWI019 Scripps Research

Scripps Research and Calibr-Skaggs awarded $4.5M from the Helmsley Charitable Trust - Scripps Research

Scripps Research and Calibr-Skaggs awarded $4.5M from the Helmsley Charitable Trust Scripps Research

Long-acting injectable malaria drug enters first-in-human study - Scripps Research

Long-acting injectable malaria drug enters first-in-human study Scripps Research

AbbVie and Calibr announce collaboration for next generation T-cell therapies - Scripps Research

AbbVie and Calibr announce collaboration for next generation T-cell therapies Scripps Research

ReFRAME drug repurposing collection yields hope for treating diseases that kill millions worldwide - Scripps Research

ReFRAME drug repurposing collection yields hope for treating diseases that kill millions worldwide Scripps Research

Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation - Frontiers

Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation Frontiers

Scripps Research scientists leveraging ReFRAME drug repurposing collection against COVID-19 coronavirus epidemic - Scripps Research

Scripps Research scientists leveraging ReFRAME drug repurposing collection against COVID-19 coronavirus epidemic Scripps Research

Caliber App Review After 21 Days of Testing (2025) - Garage Gym Reviews

Caliber App Review After 21 Days of Testing (2025) Garage Gym Reviews

Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award - Scripps Research

Calibr and TSRI Executive Matt Tremblay Receives Biocom Catalyst Award Scripps Research

Merck and partners create the California Institute for Biomedical Research (Calibr) - European Pharmaceutical Review

Merck and partners create the California Institute for Biomedical Research (Calibr) European Pharmaceutical Review

Audacious start for La Jolla’s Calibr - San Diego Union-Tribune

Audacious start for La Jolla’s Calibr San Diego Union-Tribune

Top Calibr Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant